IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type
Liu, Yupeng; Wang, Qiao; Li, Xiyuan; Ding, Yuan; Song, Jinqing; Yang, Yanling
关键词Combined methylmalonic aciduria and homocystinuria cblC type MMACHC Pregnancy
刊名BRAIN & DEVELOPMENT
2015-03-01
DOI10.1016/j.braindev.2014.06.007
37期:3页:286-291
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Clinical Neurology
研究领域[WOS]Neurosciences & Neurology
关键词[WOS]PYRIDOXINE-NONRESPONSIVE HOMOCYSTINURIA ; RISK FACTOR ; FOLIC-ACID ; HYPERHOMOCYSTEINEMIA ; WOMEN ; METABOLISM ; PROGNOSIS ; CHILDREN ; DISEASE ; GC/MS
英文摘要

Objective: Combined methylmalonic aciduria (MMA) and homocystinuria, cblC type, is the most common MMA in Mainland China. Its clinical spectrum varies from severe neonatal-onset forms, with brain injury and high mortality to milder forms with late onset. Timely diagnosis and adequate treatment greatly improve the prognosis. In the past 15 years, many Chinese patients with this condition have achieved favorable treatment outcomes, and some of them have reached childbearing age. Here, we report the first case of Chinese woman with cblC undergoing a successful pregnancy and delivering a healthy boy. Methods: A patient of late-onset cblC, who achieved successful pregnancy and delivery of a healthy boy, was enrolled in our studies. The patient and her disease characteristics were analyzed, including age at onset, age at diagnosis, clinical presentation, clinical classification, family history, laboratory findings and MMACHC gene mutation. Results: Our patient presented mild neurological symptoms at the age of 15 years. She had the compound heterozygous mutations, c.315C>G and c.482G>A, on the MMACHC gene. After long-term treatment with cobalamin, calcium folinate, 1-carnitine and betaine, along with normal diet, she recovered completely. At age 23, she visited us for genetic counseling and fetal evaluation at 15 weeks of gestation. Her general condition and the fetal growth were normal. At 20 weeks of gestation, intramuscular cobalamin was changed to pure hydroxocobalamin (1 mg, every other day) because of markedly elevated urine MMA and plasma total homocysteine. In addition, the dosages of 1-carnitine (1 g, p.o., tds), folic acid (5 mg, p.o., tds) and betaine (1 g, p.o., tds) were increased. Protein intake was not restricted. Conclusions: This is the first report of a Chinese woman with cblC, undergoing a successful pregnancy and delivering a healthy baby at term. The favorable outcome of the patient and her fetus should owe much to the mild phenotype of her disease. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

语种英语
WOS记录号WOS:000350094300003
项目编号30872794 ; 2012BAI09B04
资助机构National Nature Science Foundation of China ; 12th Five-year Plan National Key Technology R &amp ; D Program from the Ministry of Science and Technology
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61016
专题北京大学第一临床医学院
北京大学第一临床医学院_儿科
北京大学第二临床医学院_儿科
北京大学口腔医学院_义齿加工中心
作者单位Peking Univ, Hosp 1, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Liu, Yupeng,Wang, Qiao,Li, Xiyuan,et al. First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type[J]. BRAIN & DEVELOPMENT,2015,37(3):286-291.
APA Liu, Yupeng,Wang, Qiao,Li, Xiyuan,Ding, Yuan,Song, Jinqing,&Yang, Yanling.(2015).First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type.BRAIN & DEVELOPMENT,37(3),286-291.
MLA Liu, Yupeng,et al."First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type".BRAIN & DEVELOPMENT 37.3(2015):286-291.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Yupeng]的文章
[Wang, Qiao]的文章
[Li, Xiyuan]的文章
百度学术
百度学术中相似的文章
[Liu, Yupeng]的文章
[Wang, Qiao]的文章
[Li, Xiyuan]的文章
必应学术
必应学术中相似的文章
[Liu, Yupeng]的文章
[Wang, Qiao]的文章
[Li, Xiyuan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。